MedTrace Logo

PBASE System Idiopathic Rhinitis Clinical Investigation

NCT01844336 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 208

Last updated 2014-09-09

No results posted yet for this study

Summary

The purpose of this study is to evaluate the performance of the PBASE system, in terms of the efficacy of treatment in patients with idiopathic rhinitis.

Conditions

  • Idiopathic Rhinitis

Interventions

DEVICE

PBASE system 1.1 + CT100 (active treatment)

DEVICE

PBASE system 1.1 + CT100 (placebo treatment)

Sponsors & Collaborators

  • Chordate Medical

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Primary Completion
2014-08-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01844336 on ClinicalTrials.gov